ISRGIntuitive Surgical

Healthcare

$423.91-2.7% 1Y

$423.91

$332.4252 weeks$592.85

Price

-2.7%1Y

End-of-day closes, not the intraday tick.

More going right than wrong

Quality strong, no red flags, price roughly fair, growing in the filings, the market undecided.

RyuScore 63 of 100: see how it is built

What they do

To assure continued alignment with the patients and healthcare community we serve, we have adopted the Quintuple Aim as our “north star.” Starting with a focus on patients, we seek to demonstrate that our products can deliver better outcomes that are validated by rigorous, independent, and peer-reviewed evidence. Second, we aim to create better patient experiences that enable patients to get back to what matters most in their lives more quickly, with fewer complications, less pain and discomfort, and greater predictability.

In the company’s own words · 10-K filed Feb 3, 2026 · SEC EDGAR

P/E48.6

Market value$144.07B

1 year-2.7%

5 years+24%

Charts

As reported to the SEC, without any scoring.

Intuitive Surgical (ISRG) reported revenue of $2.89B in Q2 2026 (quarter ended Jun 30, 2026), up 19% from the same quarter a year earlier. That came with a gross margin of 68% and net income of $818M (28% of revenue). For the full year FY2025, revenue was $10.1B (+21% year on year) and net income $2.86B. Its largest product in Q2 2026 was Instrumentsand Accessories at $1.18B, 49% of the disclosed total, well ahead of Service at 20%. The next results filing is expected around Oct 20, 2026, the same week as a year ago.

What the company said

The company's own words from its current reports to the SEC, newest first

Jul 27, 2026On July 23, 2026, the Board of Directors of Intuitive Surgical, Inc. (the “Company”) amended and restated the Company’s Amended and Restated Bylaws (as so amended and restated, the “Amended Bylaws”) to, among other things: i. allow the Company to disregard votes for any nominee made by a shareholder that do not comply …Charter/bylaw amendment or fiscal-year change · Form 8-K
Jul 16, 2026SUNNYVALE, CALIF., July 16, 2026 – Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2026.Earnings release · press release
May 28, 2026Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Senior Vice President of Global Business Operations of the Company.Director or officer change · Form 8-K